5-[(2-chlorophenyl)sulfanyl]-6'-[(3,4-difluorophenyl)amino]-2-(6-{[(4-fluorophenyl)methyl]amino}pyridin-2-yl)-4-hydroxy-1,2,3,6-tetrahydro-[2,2'-bipyridin]-6-one

ID: ALA5196259

Chembl Id: CHEMBL5196259

PubChem CID: 168288087

Max Phase: Preclinical

Molecular Formula: C34H25ClF3N5O2S

Molecular Weight: 660.12

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1NC(c2cccc(NCc3ccc(F)cc3)n2)(c2cccc(Nc3ccc(F)c(F)c3)n2)CC(O)=C1Sc1ccccc1Cl

Standard InChI:  InChI=1S/C34H25ClF3N5O2S/c35-23-5-1-2-6-27(23)46-32-26(44)18-34(43-33(32)45,28-7-3-9-30(41-28)39-19-20-11-13-21(36)14-12-20)29-8-4-10-31(42-29)40-22-15-16-24(37)25(38)17-22/h1-17,44H,18-19H2,(H,39,41)(H,40,42)(H,43,45)

Standard InChI Key:  XLIRIXDHTSWQIN-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5196259

    ---

Associated Targets(Human)

LDHA Tchem L-lactate dehydrogenase A chain (1573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LDHB Tchem L-lactate dehydrogenase B chain (463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 660.12Molecular Weight (Monoisotopic): 659.1370AlogP: 8.23#Rotatable Bonds: 9
Polar Surface Area: 99.17Molecular Species: ACIDHBA: 7HBD: 4
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.87CX Basic pKa: 6.21CX LogP: 6.55CX LogD: 5.56
Aromatic Rings: 5Heavy Atoms: 46QED Weighted: 0.13Np Likeness Score: -1.25

References

1. Wei B, Robarge K, Labadie SS, Chen J, Corson LB, DiPasquale A, Dragovich PS, Eigenbrot C, Evangelista M, Fauber BP, Hitz A, Hong R, Lai KW, Liu W, Ma S, Malek S, O'Brien T, Pang J, Peterson D, Salphati L, Sampath D, Sideris S, Ultsch M, Xu Z, Yen I, Yu D, Yue Q, Zhou A, Purkey HE..  (2022)  Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase.,  59  [PMID:35065235] [10.1016/j.bmcl.2022.128576]
2. Wei B, Robarge K, Labadie SS, Chen J, Corson LB, DiPasquale A, Dragovich PS, Eigenbrot C, Evangelista M, Fauber BP, Hitz A, Hong R, Lai KW, Liu W, Ma S, Malek S, O'Brien T, Pang J, Peterson D, Salphati L, Sampath D, Sideris S, Ultsch M, Xu Z, Yen I, Yu D, Yue Q, Zhou A, Purkey HE..  (2022)  Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase.,  59  [PMID:35065235] [10.1016/j.bmcl.2022.128576]

Source